Thus, the Apln-CreER allele allowed us to map the fate of activated, angiogenic coronary ECs specifically during the hypoxic phase of MI recovery, but its activity was reduced on the re-establishment of a functional vasculature. The gene discussed is APLN; the disease is myocardial infarction.